No insider purchase over the last 90 days. The latest, by SMITH WAYNE T, was filed 01 Nov 2023.
Headquartered in Franklin, United States, Community Health Systems Inc belongs to the Healthcare & Pharma sector and traces its origins to 1985. Filings by its managers are published through SEC (Form 4). Over the twelve months to 22 October 2026, 41 filings were filed, from 17 insiders.
Only sales appear on the open market, 1 sale in all totalling €101k, filed by 1 insider. At €101k, the sale published on 25 August 2026 by Jennings William Norris is the largest of the period (0.028% of market cap).
Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 2,023 companies) published 41 filings over the same period, against 41 filings here. Over the whole record (from 2016), the tally stands at 49 purchases and 16 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 12.48 bn USD and net income at 509.0 m USD.
Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Community Health Systems Inc Hold (neutral), based on 8 analysts. Average price target: US$3.09.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 570 declarations
Community Health Systems, Inc. (NYSE: CYH) is a U.S. hospital operator focused on developing and running local healthcare delivery systems. Headquartered in Franklin, Tennessee, United States, the company owns and leases a broad portfolio of care assets centered on acute-care hospitals and outpatient services. In its latest public disclosures, CHS reported 69 affiliated hospitals and more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers, and ambulatory surgery centers. The business model is built around local market presence, operational standardization, physician recruitment, facility investment, and centralized support functions that are intended to improve quality and efficiency.
Founded more than 40 years ago, the company has positioned itself as one of the larger for-profit healthcare delivery systems in the United States. CHS has grown through a combination of organic development, acquisitions, and portfolio management, with a historical emphasis on community and regional markets rather than large urban academic centers. That strategy can provide scale advantages in underserved or mid-sized markets, but it also exposes the group to intense competition from nonprofit health systems, national hospital chains, independent physicians, and outpatient competitors. For investors, the key strategic variables are reimbursement rates, labor costs, volume trends, leverage, and the company’s ability to balance growth with disciplined capital allocation.
Operationally, Community Health Systems generates revenue primarily from hospital services and related outpatient care. Its core service lines include general acute care, specialty hospital services, emergency care, imaging, oncology, physician services, and ambulatory surgery. The company also emphasizes investments in medical technology, hospital upgrades, and provider recruitment across the markets where it operates. Geographically, CHS maintains a multi-state footprint across the United States; recent company materials describe a presence in roughly 13 states and 64 hospitals, with operations spanning numerous local communities.
Recent developments have centered on portfolio optimization and asset sales. In early 2026, CHS announced the sale of several Pennsylvania hospitals and also disclosed an agreement to sell Crestwood Medical Center in Alabama, reflecting continued efforts to streamline the asset base and focus on strategic markets. The company also released full-year 2025 results in February 2026, underscoring that the latest operating and balance-sheet trends are active points of investor focus. Overall, CYH is best understood as a large U.S. hospital platform listed on the NYSE, with a defensive healthcare profile, but one that remains sensitive to reimbursement pressure, staffing constraints, regulatory oversight, and ongoing deleveraging needs.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Franklin, United States · Founded: 1985 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 12.48 bn USD | 509.0 m USD | 3.77 USD | 10-K |
| Dec 2024 | 12.63 bn USD | -516.0 m USD | -3.90 USD | 10-K |
| Dec 2023 | 12.49 bn USD | -133.0 m USD | -1.02 USD | 10-K |
| Dec 2022 | 12.21 bn USD | 46.0 m USD | 0.35 USD | 10-K |
| Dec 2021 | 12.37 bn USD | 230.0 m USD | 1.76 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.